ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
6
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,712
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
BIOGEN’S SPINRAZA®(nusinersen) receives recommendation from nice for the treatment of infants, children and adults with 5q spinal muscular atrophy
Author(s):
D. ROBERTSON
Publication date:
2019
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Biomarkers for Inflammatory Lung Disease
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
2,712
SPINRAZA [Package Insert]
Authors:
Spinraza® and Zolgensma® for Spinal Muscular Atrophy: Effectiveness and Value
Authors:
A.G. Ellis
,
K Mickle
,
S. Herron-Smith
…
Guide for Patients with Spinal Muscular Atrophy and Their Caregivers Navigating Insurance and Support Programs for Spinraza®
Authors:
A. Biogen
See all similar
Cited by
1
Proxy-Reported Quality of Life and Access to Nusinersen Among Patients with Spinal Muscular Atrophy in Saudi Arabia
Authors:
Yazed AlRuthia
,
Ghadah Almuaythir
,
Hala H Alrasheed
…
See all cited by